News

Majority of panelists on controversial new cholesterol guideline have current or recent ties to drug manufacturers

BMJ 2013; 347 doi: https://doi.org/10.1136/bmj.f6989 (Published 21 November 2013) Cite this as: BMJ 2013;347:f6989